Seebri Neohaler (glycopyrrolate) is an inhaler used to treat chronic obstructive pulmonary disease (COPD). Although it was FDA approved in 2015, it's no longer available in the United States because it was discontinued.
Seebri Neohaler (glycopyrrolate) is an inhaler used to treat COPD). It's an anticholinergic that works to help you breathe easier by relaxing the muscles in your lungs and widening your airways.
No, Seebri Neohaler (glycopyrrolate) has been discontinued and is no longer available in the United States. There are no generics for this medication. It's not completely clear why Seebri Neohaler (glycopyrrolate) has been discontinued.
There are several inhalers available that are used to treat COPD. More specifically, these include Spiriva (tiotropium), Incruse Ellipta (umeclidinium), and Lonhala Magnair (glycopyrrolate). Ask your provider about the right treatment for you.